Table 1 Summary of Patient Demographics across Sample Cohorts.

From: Smoking modulates different secretory subpopulations expressing SARS-CoV-2 entry genes in the nasal and bronchial airways

 

DECAMP nose

AEGIS nose

DECAMP bronchus

AEGIS bronchus

BCLHS bronchus

PCA bronchus

Total number of samples/cells

288

505

360

938

238

137

Smoking Status (%)

Current

125 (43)

186 (37)

153 (43)

442 (47)

99 (42)

77 (56)

Former

156 (54)

319 (63)

202 (56)

496 (53)

139 (58)

60 (44)

Never

0

0

0

0

0

0

Missing

7 (2)

0

5 (1)

0

0

0

Sex, n (%)

Male

219 (76)

317 (63)

282 (78)

584 (62)

135 (57)

70 (51)

Female

69 (24)

188 (37)

78 (22)

354 (28)

103 (43)

67 (49)

Missing

0

0

0

0

0

0

Age

Mean (SD)

67 (8)

60 (11)

65 (7)

63 (11)

65 (6)

58 (7)

Missing

0

0

0

0

0

0

FEV1 (% predicted)

Mean (SD)

75 (19)

73 (21)

73 (20)

69 (22)

81 (21)

74 (21)

Missing

28

355

0

633

0

4

Having lung cancer (%)

Yes

NA

309 (61)

NA

710 (76)

NA

NA

No

NA

196 (39)

NA

228 (24)

NA

NA

Missing

NA

0

NA

0

NA

NA

  1. Definition of abbreviations: DECAMP: Detection of Early Lung Cancer Among Military Personnel, AEGIS: Airway Epithelial Gene expression in the Diagnosis of Lung Cancer, BCLHS: British Columbia Lung Health Study and Pan-Canadian Lung Health Study, PCA: Pre-Cancer Atlas. Values are presented as mean (standard deviation).